Still River Systems in MIT Tech Review 9-5-2006

Embed Size (px)

Citation preview

  • 8/14/2019 Still River Systems in MIT Tech Review 9-5-2006

    1/3

    Tuesday, September 05, 2006

    A Cheaper Way to Zap TumorsA smaller cyclotron could bring proton radiation therapy to more patients.

    By Katherine Bourzac

    Half of all cancer patients in the United States require radiation to combat their tumors.

    A form of radiation that uses protons, rather than X rays, to zap tumors causes fewer

    side effects to healthy tissue and may prove more effective.

    Although these benefits of proton therapy have been known since the 1960s, it has yetto come into wide use. A key drawback: cost. Only a handful of hospitals can afford

    the equipment required to create high-energy proton beams.

    Now a startup based in Littleton, MA, Still River Systems, is working with MIT

    physicists to develop a smaller, less expensive proton accelerator in the hopes of

    making the therapy more widely available. It expects the machine, which relies on

    advances in magnet technology to energize protons enough so they are therapeutic, to

    be in hospital trials in 2008.

    During traditional radiation therapy, a clinician aims X-ray beams at a patient's tumor.

    The X rays damage DNA and other molecules in the cancer cells--and in healthy cells-

    -in the beam's path. Proton beams can be focused far more sharply. "You can more

    precisely shape the [proton] dose to the shape and thickness of the tumor," says

    Timothy Antaya, a technical supervisor at MIT's Plasma Science and Fusion Center,

    who is working with Still River Systems. As a result, less surrounding healthy tissue is

    damaged during proton therapy.

    But giving protons high enough energy to penetrate through the body to a tumor

    usually requires a large, expensive accelerator that must be housed in a different room

    than the patient. In order to penetrate 20 centimeters of water (the gold standard for

    these treatments), accelerators must rev up protons to 250 million electron volts. The

    equipment needed to generate such high-energy proton beams costs $100-200 million.

    Furthermore, in staffing, Antaya says, "For protons you need something like a small

    nuclear physics laboratory."

    Page 1 of 3Technology Review: A Cheaper Way to Zap Tumors

    4/11/2009http://www.technologyreview.com/printer_friendly_article.aspx?id=17418&channel=biom...

  • 8/14/2019 Still River Systems in MIT Tech Review 9-5-2006

    2/3

    Antaya says the machine from Still River Systems will be small enough to fit into the

    same room as the patient. "We're taking advantage of advanced magnet technology,"

    he says. The company is using an accelerator known as a synchrocyclotron. Antaya

    says the new machines will be an order of magnitude smaller and an order of

    magnitude less expensive than current ones. And he says one of the group's goals is togive the system a simple interface so that it doesn't require a large, highly-trained staff.

    Currently, only four hospitals in the United State have proton beam facilities, in

    Massachusetts, Indiana, California, and Texas (ones in Florida and Pennsylvania

    are under development). "If protons become more available, a lot of patients could

    benefit," says Jay Loeffler, chief of radiation oncology at Massachusetts General

    Hospital in Boston, which has operated a proton beam since 2001. The hospital

    currently gives proton therapy to 60 patients a day.

    Because proton beam therapy has not been in wide use, it is not clear which patients it

    could benefit the most. Clinicians know that the biggest benefits come in patients

    whose cancer has not yet spread beyond its initial site, and that children almost always

    benefit, says Loeffler. Protons generally work as well as, or better than, X rays, and

    with fewer side effects, he explains. Ongoing clinical trials will help clarify which

    patients benefit the most from the therapy. Loeffler says patients whose cancer has

    been discovered in its early stages are currently chosen for proton treatment.

    Loeffler cautions that because Still River Systems has been secretive about its

    technology, its new approach hasn't been evaluated by outside experts. Having a

    proton facility the same size as an X-ray facility is attractive, he says; but for the

    proton accelerator to be in the same room as the patient it must be proved safe--

    cyclotrons can give off stray radiation, as well as using tremendous voltage and power.

    Antaya says that his group has taken safety into account from the beginning and that

    the design includes "sophisticated shielding and control of the surrounding

    environment." Many hospitals have expressed interest in Still River Systems' protontherapy, he adds.

    Copyright Technology Review 2006.

    Upcoming Events

    Page 2 of 3Technology Review: A Cheaper Way to Zap Tumors

    4/11/2009http://www.technologyreview.com/printer_friendly_article.aspx?id=17418&channel=biom...

  • 8/14/2019 Still River Systems in MIT Tech Review 9-5-2006

    3/3

    2009 Medical Innovation Summit

    Cleveland, OH

    Monday, October 05, 2009 - Wednesday, October 07, 2009

    http://www.ClevelandClinic.org/innovations/summit

    Cleantech Capital SummitSan Diego, CA

    Wednesday, April 22, 2009 - Friday, April 24, 2009

    http://www.infocastinc.com/cleantech

    MIT Sustainability Summit: Discovering New Dimensions for Growth

    Cambridge, MA

    Friday, April 24, 2009

    http://sustainabilitysummit.mit.edu/

    The Front End of Innovation

    Boston, MA

    Monday, May 18, 2009 - Wednesday, May 20, 2009

    http://www.iirusa.com/feiusa/fei-home.xml

    MIT Sloan CIO Symposium: Sustaining CIO Leadership in a Changing Economy

    Cambridge, MA

    Wednesday, May 20, 2009

    http://www.mitcio.com/

    Page 3 of 3Technology Review: A Cheaper Way to Zap Tumors

    4/11/2009http://www technologyreview com/printer friendly article aspx?id=17418&channel=biom